Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins
E S Reis1, D A Falcão, L Isaac
1Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil.
Insights
Complement C3 deficiencies, though uncommon, increase susceptibility to severe infections and autoimmune diseases. Understanding these deficiencies is crucial for diagnosis and management.
Area of Science:
- Immunology
- Genetics
Background:
- The complement system is vital for innate and adaptive immunity.
- Complement deficiencies are often underestimated and require specialized diagnostics.
- C3 is a central component, crucial for all complement activation pathways.
Purpose of the Study:
- To review the clinical and molecular aspects of primary C3 deficiency.
- To examine secondary C3 deficiencies caused by mutations in Factor I and Factor H.
- To discuss the utility of animal models in studying complement deficiencies.
Main Methods:
- Literature review of clinical manifestations and molecular genetics.
- Analysis of regulatory protein mutations leading to C3 deficiency.
- Examination of data from animal models.
Main Results:
- C3 deficiency is linked to increased risk of severe infections.
- Autoimmune diseases, like lupus erythematosus, can be associated with C3 deficiency.
- Mutations in Factor I and Factor H can lead to secondary C3 deficiency.
Conclusions:
- Primary and secondary C3 deficiencies have significant clinical implications.
- Further research, including animal models, is valuable for understanding complement deficiencies.
- Improved diagnostic approaches are needed for these rare conditions.
Abstract:
The complement system participates in both innate and acquired immune responses. Deficiencies in any of the protein components of this system are generally uncommon and require specialized services for diagnosis. Consequently, complement deficiencies are clinically underscored and may be more common than is normally estimated. As C3 is the major complement component and participates in all three pathways of activation, it is fundamental to understand all the clinical consequences observed in patients for which this protein is below normal concentration or absent in the serum. C3 deficiencies are generally associated with higher susceptibility to severe infections and in some cases with autoimmune diseases such as systemic lupus erythematosus. Here, we review the main clinical aspects and the molecular basis of primary C3 deficiency as well as the mutations in the regulatory proteins factor I and factor H that result in secondary C3 deficiencies. We also discuss the use of animal models to study these deficiencies.
Related Concept Videos
01:27Complement System
01:36Humoral Immune Responses
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
01:23Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:19Hypersensitivity Reactions: Immune-Complex Reactions